Trial intelligence / Profile preview

Lacidipine in Chronic Stable Angina

NCT02232607Phase 2Completed

Sponsor
Boehringer Ingelheim
Start
Apr 1998
Primary completion
Jun 1999
Modality
Small Molecules
01

Overview

A Phase 2 trial of lacidipine in angina pectoris, sponsored by Boehringer Ingelheim. Started Apr 1998; status: completed.

02

Drugs

lacidipine
03

Conditions

angina pectoris

Beyond the preview

Go deeper on NCT02232607.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02232607.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call